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gDespite competition from new measures at rest and
on exertion (1), the assessment of ejection fraction
(EF) from 2-dimensional echocardiography is likely
the most widely used number in cardiology, if not in
internal medicine. Its prognostic value has led to its
use in the selection of patients for a variety of
treatments, especially in heart failure (2). Despite
criticisms relating to dependence on loading condi-
tions, the significant test/retest variability of this
test (driven in part by biological variation), and
See page 821
dependence on image quality and geometric as-
sumptions, the simplicity of this measure is perhaps
the biggest clue to its enduring use. However, the
sources of variation in EF represent an important
ongoing limitation (3). The implications of these
variations extend from the minor annoyance of
differences in measurement within sequential stud-
ies that are clearly normal or clearly abnormal,
extending to variations across thresholds that imply
suitability for device therapy. At the worst extreme,
indications for device therapy may change from 1
visit to the next.
The avoidance of the shortcomings can be based
upon quantitation or education, or a combination of
both. In this issue of iJACC, investigators from
Massachusetts General Hospital describe a very
important teaching intervention to reduce interob-
server variability in the assessment of EF whereby
participants attended 6 1-h sessions over a 6-month
*Editorials published in JACC: Cardiovascular Imaging reflect the views of
the authors and do not necessarily represent the views of JACC: Cardio-
vascular Imaging or the American College of Cardiology.
From the Cleveland Clinic, Cleveland, Ohio. Dr. Marwick has reporteds
that he has no relationships relevant to the contents of this paper to
disclose.eriod (4). The baseline status of the EF estima-
ions was gathered in the first session, the next 3
nvolved a case-based approach to obtaining con-
ensus, culminating in the 2 final sessions, where
ew cases were measured with feedback. A sub-
roup participated in a follow-up session a year
ater. The results of the 25 readers demonstrated
hat a very impressive 40% reduction of interob-
erver variability from 14% of EF prior to interven-
ion. Indeed, this improvement was sustained over
2 months of follow-up. This improvement also
ccurred in the mid-range of EF, where the mis-
lassification rate was even higher than in the group
verall. The findings of this study leave us with 3
mportant messages—about the importance of
uality control, the role of quantitation, and the
ariability of EF.
The core message of this study is not only its
ontent about EF, but also its lesson about quality
ontrol activities in the imaging laboratory. The
merican Society of Echocardiography has empha-
ized the importance of reducing interobserver vari-
bility (5). Although this is a problem with EF, it is
uch more a problem with complex multiparamet-
ic parameters, where the hierarchy of individual
arameters is not provided by the guidelines, and
herefore, patients with discordant findings may be
eadily classified differently by different observers.
rominent examples of these multiparametric eval-
ations include assessment of regurgitant heart
alves and the assessment of diastolic dysfunction
6). Indeed, the limited literature on variability in
alve evaluation suggests that there is a high degree
f variability between observers that ranges all the
ay from differing assessments of suitability for
alvuloplasty (7) to differing assessments of regur-
itation severity that may have implications for the
election for surgery (8).
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831In response to heightened concern about medical
costs and quality, there has been success in improv-
ing quality, although much work remains to be
done (9). Some variation in practice may reflect
failure to adopt practice guidelines; interestingly,
although often attributed to disagreement with
guidelines, this appears at least as much due to a
variety of reasons, including unfamiliarity and lack
of awareness (10). Both guidelines review and
concordance reading should be part of the continu-
ing education activities of every imaging laboratory,
and a number of observations from this paper and
the literature may guide us to the successful possible
strategies for achieving this. First, this is more likely
to be successful as an active rather than a passive
process (11). The use of a regularly scheduled
conference time and clear leadership of this activity
by senior laboratory members is absolutely manda-
tory. A case-based strategy of practice, rehearsal,
and performance is effective in teaching other skills
that require recognition and hand– eye co-
ordination (12). The process of gaining consensus
by the group working together is important, and as
this can be confronting, needs to be performed in a
nonjudgmental environment. Finally, continuous
feedback and quality control are vital components
of this process, and should be addressed by perfor-
mance of an entry and an exit task. Indeed, in
addition to EF evaluation, many other aspects of
imaging require the evolution of this process, the
presentation of which is timely and overdue.
The second message of this paper is about quan-
titation, potentially an important weapon in the
avoidance of variation. Despite encouragement to
adopt quantitative analysis (13), the stubborn at-
tachment of most clinicians to qualitative evaluation
is understandable. The assessment of global left
ventricular (LV) systolic function is not necessarily
well represented by end-systolic and end-diastolic
frames, which neglect the speed and co-ordination
of contraction. In many settings, poor delineation of
endocardial borders constrains the ability to trace
LV volume, and although this may be rectified by
LV opacification, incorporation of contrast into the
routine is limited by challenges pertaining to cost,In the same study, the 5 sonographers who
measured LV volumes initially demonstrated a
standard deviation from the biplane EF of approx-
imately 4%, which was reduced to 2.5% following
intervention. This led to an interobserver variability
of 6%, falling to 3% EF post-intervention. This is a
remarkably good response to quantitative training,
and although the authors have proposed the train-
ing strategy as a means of reducing variability, these
results alone would suggest that quantitation is an
important part of the solution of this problem. An
alternative quantitative strategy might be the incor-
poration of new technologies such as global longi-
tudinal strain, which correlates loosely with EF but
also appears to add to the discrimination of risk,
especially in patients with mild dysfunction (15).
Indeed, in addition to the assessment of strain, new
software approaches to EF measurement may limit
variability, because the software identifies the same
landmarks and edges whenever it is presented with
the same image.
The final message is perhaps the most impor-
tant: the estimation of EF is inherently variable.
Previous investigators have published the 95%
confidence intervals of EF from repeat 2-
dimensional echocardiograms to exceed 10%.
Even following the intervention in this paper, the
interobserver variability of EF was 8.4%. Track-
ing treatment response requires a better-
performing measure for careful assessment of the
progression of LV dysfunction. This is becoming
apparent in the field of cardio-oncology (16), as
well as other disorders of pre-clinical LV dys-
function, and this need will become more acute as
stem cell therapy evolves into clinical practice.
Johri et al. (4) have provided an exemplary study
of how to incorporate quality improvement into
the imaging laboratory, but the paper also re-
minds us of the need for a sensitive, robust, and
reproducible marker of LV function.
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